The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Oxidative Stress in Neurodegeneration
Open accessAbstract
It has been demonstrated that oxidative stress has a ubiquitous role in neurodegenerative diseases. Major source of oxidative stress due to reactive oxygen species (ROS) is related to mitochondria as an endogenous source. Although there is ample evidence from tissues of patients with neurodegenerative disorders of morphological, biochemical, and molecular abnormalities in mitochondria, it is still not very clear whether the oxidative stress itself contributes to the onset of neurodegeneration or it is part of the neurodegenerative process as secondary manifestation. This paper begins with an overview of how oxidative stress occurs, discussing various oxidants and antioxidants, and role of oxidative stress in diseases in general. It highlights the role of oxidative stress in neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis. The last part of the paper describes the role of oxidative stress causing deregulation of cyclin-dependent kinase 5 (Cdk5) hyperactivity associated with neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,793
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,941
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Cellular defenses against damage from reactive oxygen species
Yu, B. P. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,370
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,347
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Hydrogen peroxide sensing and signaling
Veal, E. A., Day, A. M., & Morgan, B. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.016 · Cited by 1,604
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Neurotoxicity induces cleavage of p35 to p25 by calpain
Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L.-H. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,063
Dhavan, R., & Tsai, L.-H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096019 · Cited by 1,058
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis
Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808
Role of reactive oxygen species in cell signalling pathways
Hancock, J. T., Desikan, R., & Neill, S. J. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290345 · Cited by 806
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Kong, J., & Xu, Z. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03241.1998 · Cited by 723
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501282102 · Cited by 701
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Reactive oxygen species: oxidative damage and pathogenesis
Bandyopadhyay, U., Das, D. K., & Banerjee, R. K. (1999) · Cited by 695
Zhang, J., Perry, G., Smith, M. A., Robertson, D., Olson, S. J., Graham, D. G., & Montine, T. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65396-5 · Cited by 636
Mattiazzi, M., D'Aurelio, M., Gajewski, C. D., Martushova, K., Kiaei, M., Beal, M. F., & Manfredi, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203065200 · Cited by 616
Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609
Estévez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., & Beckman, J. S. (1999) · Science · doi:10.1126/science.286.5449.2498 · Cited by 596
Rethinking ALS: The FUS about TDP-43
Lagier-Tourenne, C., & Cleveland, D. W. (2009) · Cell · doi:10.1016/j.cell.2009.03.006 · Cited by 588
Goldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 581
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Xu, Y.-F., Gendron, T. F., Zhang, Y.-J., Lin, W.-L., D'Alton, S., Sheng, H., Casey, M. C., Tong, J., Knight, J., Yu, X., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1630-10.2010 · Cited by 555
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Protein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
TDP‐43 is recruited to stress granules in conditions of oxidative insult
Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., Silani, V., & Ratti, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06383.x · Cited by 539
Freibaum, B. D., Chitta, R. K., High, A. A., & Taylor, J. P. (2010) · Journal of Proteome Research · doi:10.1021/pr901076y · Cited by 514
Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria
Liu, J., Lillo, C., Jonsson, P. A., Velde, C. V., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S., Andersen, P. M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.016 · Cited by 506
Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., & Brown, R. H. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.021 · Cited by 506
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
Sánchez, I., Mahlke, C., & Yuan, J. (2003) · Nature · doi:10.1038/nature01301 · Cited by 503
Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease
Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483
Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 478
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Barber, S. C., Mead, R. J., & Shaw, P. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.008 · Cited by 474
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452
Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M., Bellen, H., & Mardon, G. (2004) · Development · doi:10.1242/dev.01095 · Cited by 443
Tau phosphorylation: physiological and pathological consequences
Stoothoff, W. H., & Johnson, G. V. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 442
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435
Lunkes, A., Lindenberg, K. S., Ben-Haı̈em, L., Weber, C., Devys, D., Landwehrmeyer, G. B., Mandel, J.-L., & Trottier, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00602-0 · Cited by 416
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Pedersen, W. A., Fu, W., Keller, J. N., Markesbery, W. R., Appel, S., Smith, R. G., Kasarskis, E., & Mattson, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440518 · Cited by 391
Role of oxidative DNA damage in cancer initiation and promotion.
Poulsen, H. E., Priemé, H., & Loft, S. H. (1998) · PubMed · Cited by 390
Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 377
Role of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001475200 · Cited by 358
The Relevance of Iron in the Pathogenesis of Parkinson's Disease
GÖTZ, M. E., DOUBLE, K., GERLACH, M., YOUDIM, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342
Deregulation of Cdk5 in a Mouse Model of ALS
Nguyen, M. D., Larivière, R. C., & Julien, J.-P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 338
Petit, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa, H., Salehi-Rad, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505143200 · Cited by 329
Understanding the molecular causes of Parkinson's disease
Wood-Kaczmar, A., Gandhi, S., & Wood, N. W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.007 · Cited by 327
Kennedy, G., Spence, V. A., McLaren, M., Hill, A., Underwood, C., & Belch, J. J. F. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.020 · Cited by 325
2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications
Kang, S. W., Rhee, S. G., Chang, T.-S., Jeong, W., & Choi, M. H. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.10.006 · Cited by 323
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
Castellani, R., Smith, M. A., Richey, G. L., & Perry, G. (1996) · Brain Research · doi:10.1016/0006-8993(96)00729-9 · Cited by 315
Perry, G., Nunomura, A., Hirai, K., Zhu, X., Prez, M., Avila, J., Castellani, R. J., Atwood, C. S., Aliev, G., Sayre, L. M., et al. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01113-9 · Cited by 297
Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E., & Masliah, E. (2004) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 295
Kikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Hisanaga, K., Sato, N., Nunomura, A., Castellani, R. J., Perry, G., Smith, M. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0466 · Cited by 289
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Milakovic, T., & Johnson, G. V. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504749200 · Cited by 261
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258
Amyotrophic lateral sclerosis: A proposed mechanism
Okado-Matsumoto, A., & Fridovich, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132260399 · Cited by 247
Regulation of Peroxiredoxin I Activity by Cdc2-mediated Phosphorylation
Chang, T.-S., Jeong, W., Choi, S. Y., Yu, S., Kang, S. W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110432200 · Cited by 244
Iijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. C., & Suzuki, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751085.x · Cited by 234
Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Lee, M., Hyun, D., Halliwell, B., & Jenner, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232
Lipoprotein glycation and its metabolic consequences
Lyons, T. J., & Jenkins, A. J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00008 · Cited by 232
Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis
Rakhit, R., & Chakrabartty, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.004 · Cited by 232
Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease
Parker, W. D., Boyson, S. J., Luder, A. S., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1231 · Cited by 230
Meulener, M. C., Xu, K., Thomson, L., Ischiropoulos, H., & Bonini, N. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601891103 · Cited by 230
Fredenburg, R. A., Rospigliosi, C., Meray, R. K., Kessler, J. C., Lashuel, H. A., Eliezer, D., & Lansbury, P. T. (2007) · Biochemistry · doi:10.1021/bi7000246 · Cited by 227
Oxidative Stress and Motor Neurone Disease
Cookson, M. R., & Shaw, P. J. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00217.x · Cited by 222
Chang, Y., Kong, Q., Shan, X., Tian, G., Ilieva, H., Cleveland, D. W., Rothstein, J. D., Borchelt, D. R., Wong, P. C., & Lin, C.-L. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002849 · Cited by 219
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
Klivenyi, P., Siwek, D., Gardian, G., Yang, L., Starkov, A., Cleren, C., Ferrante, R. J., Kowall, N. W., Abeliovich, A., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.018 · Cited by 213
Zhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N., & Freed, C. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02215-0 · Cited by 204
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains
Tseng, H.-C., Zhou, Y., Shen, Y., & Tsai, L.-H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02934-4 · Cited by 198
Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases
Luo, S., Vacher, C., Davies, J. E., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412071 · Cited by 195
Smith, M. A. (1998) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60607-8 · Cited by 194
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
Zheng, Y., Kesavapany, S., Gravell, M., Hamilton, R. S., Schubert, M., Amin, N., Albers, W., Grant, P., & Pant, H. C. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600441 · Cited by 189
Self-citationLee, V. M.-Y., Giasson, B. I., & Trojanowski, J. Q. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.01.007 · Cited by 187
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)
Strong, M. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.029 · Cited by 183
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
Piedrahita, D., Hernández, I., López-Tobón, A., Fedorov, D., Obara, B., Manjunath, B. S., Boudreau, R. L., Davidson, B., LaFerla, F., Gallego-Gómez, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3637-10.2010 · Cited by 183
IMAM, S. Z., EL‐YAZAL, J., NEWPORT, G. D., ITZHAK, Y., CADET, J. L., SLIKKER, W., & ALI, S. F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03646.x · Cited by 173
Kazantsev, A., Walker, H. A., Slepko, N., Bear, J. E., Preisinger, E., Steffan, J. S., Zhu, Y.-Z., Gertler, F. B., Housman, D. E., Marsh, J. L., et al. (2002) · Nature Genetics · doi:10.1038/ng864 · Cited by 172
Current approaches in the treatment of Alzheimer's disease
Shah, R. S., Lee, H.-G., Xiongwei, Z., Perry, G., Smith, M. A., & Castellani, R. J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.02.005 · Cited by 172
Castellani, R. J., Perry, G., Siedlak, S. L., Nunomura, A., Shimohama, S., Zhang, J., Montine, T., Sayre, L. M., & Smith, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02514-9 · Cited by 169
Bowie, A., Owens, D., Collins, P., Johnson, A., & Tomkin, G. H. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90084-8 · Cited by 166
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease
Zhu, X., Rottkamp, C. A., Hartzler, A., Sun, Z., Takeda, A., Boux, H., Shimohama, S., Perry, G., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00597.x · Cited by 162
Cras, P. P., Smith, M. A., Richey, P. L., Siedlak, S. L., Mulvihill, P., & Perry, G. L. (1995) · Acta Neuropathologica · doi:10.1007/bf00309621 · Cited by 162
Pathogenetic mechanisms of parkin in Parkinson's disease
Hattori, N., & Mizuno, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16901-8 · Cited by 162
Gitcho, M. A., Bigio, E. H., Mishra, M., Johnson, N., Weintraub, S., Mesulam, M., Rademakers, R., Chakraverty, S., Cruchaga, C., Morris, J. C., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0571-7 · Cited by 161
Cdk5 behind the wheel: a role in trafficking and transport?
Smith, D. S., & Tsai, L.-H. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02181-x · Cited by 159
Anne, S. L., Saudou, F., & Humbert, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1831-07.2007 · Cited by 159
Lipoprotein Glycation and Its Metabolic Consequences
Lyons, T. J. (1992) · Diabetes · doi:10.2337/diab.41.2.s67 · Cited by 159
Jones, D. C., Gunasekar, P. G., Borowitz, J. L., & Isom, G. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742296.x · Cited by 157
Role of inflammatory markers in brain ischemia
Rodríguez‐Yáñez, M., & Castillo, J. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ffafbf · Cited by 156
Butterworth, J., Yates, C. M., & Reynolds, G. P. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90112-1 · Cited by 150
Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation
Iqbal, K., Zaidi, T., Bancher, C., & Grundke, I. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00650-4 · Cited by 150
Truncation of CDK5 Activator p35 Induces Intensive Phosphorylation of Ser202/Thr205 of Human Tau
Hashiguchi, M., Saito, T., Hisanaga, S., & Hashiguchi, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207426200 · Cited by 149
Oxidative Damage to RNA in Neurodegenerative Diseases
Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 148
Mitochondrial function and parental sex effect in Huntington's disease
Mann, V. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92242-a · Cited by 147
Filaments of Lewy bodies contain insoluble cytoskeletal elements.
Galloway, P. G., Mulvihill, P., & Perry, G. L. (1992) · PubMed · Cited by 133
Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction
Sun, K., de Pablo, Y., Vincent, F., & Shah, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05616.x · Cited by 130
Avraham, E., Rott, R., Liani, E., Szargel, R., & Engelender, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608243200 · Cited by 129
Does cellular iron dysregulation play a causative role in Parkinson’s disease?
Kaur, D., & Andersen, J. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.003 · Cited by 123
Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy
Lim, J., Balaštík, M., Lee, T. H., Nakamura, K., Liou, Y., Sun, A., Finn, G., Pastorino, L., Lee, V. M. ‐., & Lu, K. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34308 · Cited by 123
Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism
Grant, P. G., Sharma, P., & Pant, H. C. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02025.x · Cited by 114
Self-citationCdk5: One of the links between senile plaques and neurofibrillary tangles?
Lee, M.-S., & Tsai, L. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5207 · Cited by 112
Goebel, H. H., Heipertz, R., Scholz, W. W., Iqbal, K., & Tellez-Nagel, I. (1978) · Neurology · doi:10.1212/wnl.28.1.23 · Cited by 108
Li, B., Zhang, L., Gu, J., Amin, N. D., & Pant, H. C. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06055.2000 · Cited by 107
Self-citationThe basic aspects of therapeutics in amyotrophic lateral sclerosis
Strong, M. J. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00040-8 · Cited by 105
MacDonald, M. E., Ginés, S., Gusella, J. F., & Wheeler, V. C. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:7 · Cited by 104
Nordlund, A., & Oliveberg, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601696103 · Cited by 103
Pathogenic superoxide dismutase structure, folding, aggregation and turnover
Hart, P. J. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.02.034 · Cited by 100
Generation of the Neurotoxin 6-Hydroxydopamine by Peroxidase/H2O2 Oxidation of Dopamine
Napolitano, A., Crescenzi, O., Pezzella, A., & Prota, G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00006a010 · Cited by 95
Gusella, J. F., & MacDonald, M. E. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90011-x · Cited by 93
Zheng, Y., Li, B., Amin, N. D., Albers, W., & Pant, H. C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03133.x · Cited by 91
Self-citationFailure of protein quality control in amyotrophic lateral sclerosis
Kabashi, E., & Durham, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.006 · Cited by 90 · cited 1×
“Misfolded aggregates are insoluble and are not cleared by proteasomal degradation, therefore they eventually impair and ultimately overwhelm the system [46, 47].”
BackgroundCyclin‐dependent kinase 5 (cdk5) activation requires interaction with three domains of p35
Amin, N. D., Albers, W., & Pant, H. C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10116 · Cited by 81
Self-citationCdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease
Chang, K., de Pablo, Y., Lee, H., Lee, H., Smith, M. A., & Shah, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06687.x · Cited by 79
Huntington?s disease: pathomechanism and therapeutic perspectives
G�rdi�n, G., & V�csei, L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0201-4 · Cited by 77
Pant, A. C., Veeranna, Pant, H. C., & Amin, N. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00561-1 · Cited by 67
Self-citationOxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington’s Disease
del Hoyo, P., García‐Redondo, A., Bustos, F., Molina, J. A., Sayed, Y., Alonso‐Navarro, H., Caballero, L., Arenas, J., & Jiménez‐Jiménez, F. J. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9110-2 · Cited by 66
Iseki, E., Marui, W., Kosaka, K., & Uéda, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00178-0 · Cited by 65
Causes of neuronal death in Parkinson's disease.
Schapira, A. H. V. (2001) · PubMed · Cited by 65
Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease
Alvira, D., Ferrer, I., Cuesta, J., García‐Castro, B., Pallàs, M., & Camins, A. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.005 · Cited by 64
Defective Neurofilament Transport in Mouse Models of Amyotrophic Lateral Sclerosis: A Review
Rao, M. V., & Nixon, R. A. (2003) · Neurochemical Research · doi:10.1023/a:1023259207015 · Cited by 62
CDK‐5‐Mediated Neurofilament Phosphorylation in SHSY5Y Human Neuroblastoma Cells
Sharma, M., Sharma, P., & Pant, H. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730079.x · Cited by 62
Self-citationDavies, S., & Ramsden, D. B. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.409 · Cited by 55
SHEA, T. B., Zheng, Y., Ortiz, D., & Pant, H. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20099 · Cited by 55
Self-citationMizusawa, H., Ishii, T., & Bannai, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00910-1 · Cited by 50
Chalmers, R. M., Brockington, M., Howard, R., Lecky, B. R. F., MORGAN-HUGHES, J. A., & Harding, A. E. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00032-9 · Cited by 49
de la Monte, S. M., Ganju, N., Feroz, N., Luong, T., Banerjee, K., Cannon, J., & Wands, J. R. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-406 · Cited by 48
Kaminosono, S., Saito, T., Oyama, F., Ohshima, T., Asada, A., Nagai, Y., Nukina, N., & Hisanaga, S.-I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0973-08.2008 · Cited by 48
Kikuchi, S., Shinpo, K., Ogata, A., Tsuji, S., Takeuchi, M., Makita, Z., & Tashiro, K. (2002) · Amyotrophic Lateral Sclerosis · doi:10.1080/146608202760196020 · Cited by 48
Biomarkers of Oxidative Stress in Heart Failure
Trachtenberg, B. H., & Hare, J. M. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.04.003 · Cited by 46
Up‐regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR‐32 cells
Strocchi, P., Pession, A., & Dozza, B. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10391 · Cited by 40
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports
Siciliano, G. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.5.685 · Cited by 38
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5
Kesavapany, S., Zheng, Y., Amin, N. D., & Pant, H. C. (2007) · Biotechnology Journal · doi:10.1002/biot.200700057 · Cited by 34
Self-citationRudrabhatla, P., Zheng, Y., Amin, N. D., Kesavapany, S., Albers, W., & Pant, H. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801633200 · Cited by 32
Self-citationIncreased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
(2000) · doi:10.1002/1531-8249(200011)48:5<730::aid-ana6>3.0.co;2-0
Cited by
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,127
Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 586
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Metadata
- Authors
- Shukla, V., Mishra, S. K., & Pant, H. C.
- Venue
- Advances in Pharmacological Sciences
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-13
- ISSN
- 1687-6334 (ISSN-L)
- 1687-6342
- OpenAlex
- W2133064681
- Cited by
- 288
- References
- 161
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.